Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial

2010605 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet

Volume 376, Issue 9739, pp. 431-439

Field-Weighted Citation Impact: 48.58